IMPINGEMENT SYNDROME MARKET ANALYSIS

Global impingement syndrome market size is estimated to value at US$ 1,380.4 million in 2023 and is expected to reach US$ 2,224 million by 2030, exhibiting a compound annual growth rate (CAGR) of 7% from 2023 to 2030.

 The increasing prevalence of shoulder-related disorders, advancements in surgical techniques, and growing demand for minimally invasive procedures are some of the factors contributing to the growth of the global impingement syndrome market.

Impingement syndrome is a common orthopedic condition which is characterized by the compression or impingement of the rotator cuff tendons and subacromial bursa within the shoulder joint. This condition typically results from the narrowing of the subacromial space, leading to pain, inflammation, and restricted mobility in the shoulder. Impingement syndrome can be classified into two main categories: primary and secondary. Primary Impingement syndrome is often related to anatomical factors such as bone spurs or structural abnormalities in the shoulder, while secondary impingement syndrome is typically caused by overuse, muscle imbalances, or repetitive activities, especially in athletes and individuals who engage in overhead movements.

Global Impingement Syndrome Market Regional Insights

• North America: North America has a well-established healthcare infrastructure and a high prevalence of impingement syndrome. The market in this region is driven by factors such as a large patient population, advanced diagnostic techniques, and a strong focus on research and development. The U.S. is a major contributor to the impingement syndrome market in North America and this region holds a substantial percentage of the market share, accounting for approximately 38.5%.
• Europe: Europe also has a significant impingement syndrome market, with countries like Germany, the U.K., and France being major contributors. The region benefits from advanced healthcare systems, a well-developed orthopedic industry, and a high prevalence of shoulder-related conditions. Government initiatives to improve patient care and increasing awareness about musculoskeletal disorders further contribute to the market growth. Europe holds around 28.6% of the market share.
• Asia Pacific: The impingement syndrome market in Asia Pacific is expected to witness significant growth due to factors such as a large population, increasing healthcare expenditure, and rising awareness about orthopedic conditions. Countries like China, Japan, and India are expected to drive market growth in this region. Asia Pacific accounts for approximately 20.9% of the market share.

Figure 1. Global Impingement Syndrome Market Share (%), By Region, 2023

To learn more about this report, request sample copy

Analyst’s View of the Global Impingement Syndrome Market:

• Global impingement syndrome market is witnessing significant growth and is expected to continue on an upward trajectory in the near future. Impingement syndrome which is also known as subacromial impingement or shoulder impingement is a common musculoskeletal disorder that affects a substantial portion of the population. It is characterized by the compression or irritation of the rotator cuff tendons in the shoulder, thus leading to pain and limited mobility. Several factors are contributing to the expansion of this market.
• Moreover, advancements in medical technology and diagnostic tools are propelling the market growth. Improved imaging techniques, such as magnetic resonance imaging (MRI) and ultrasound, enable more accurate and early diagnosis of impingement syndrome. This early detection is crucial for effective treatment and management of the condition.

Global Impingement Syndrome Market Drivers:

• Increasing prevalence: The prevalence of impingement syndrome is on the rise due to various factors such as aging populations, sedentary lifestyles, and the growing number of individuals participating in repetitive overhead activities. As the incidence of impingement syndrome continues to increase, the demand for treatment options also rises, thus driving the market growth.
• Rising awareness and diagnosis: Improved awareness among patients and healthcare professionals regarding shoulder impingement syndrome has led to an increase in diagnosis rates. With greater recognition of the condition, individuals seek medical attention, thus leading to a higher demand for treatment options. The market is positively impacted by this increased awareness and timely diagnosis.
• Advancements in diagnostic technologies: The development of advanced diagnostic technologies, such as magnetic resonance imaging (MRI) and ultrasound, has facilitated accurate and early diagnosis of impingement syndrome. These technologies enable healthcare professionals to visualize the shoulder structures and identify the specific causes of impingement, thereby leading to targeted treatment approaches. The availability of these diagnostic tools has driven the market growth by improving the precision and effectiveness of treatment.

Global Impingement Syndrome Market Opportunities:

• New treatment modalities: There is an opportunity to develop and introduce innovative treatment modalities for impingement syndrome. This includes exploring novel pharmaceutical interventions, such as targeted drug therapies or regenerative medicine approaches that can provide more effective and long-lasting relief for patients. Incorporating emerging technologies like shockwave therapy or electromagnetic field therapy may offer alternative treatment options for individuals with impingement syndrome.
• Patient education and self-management: Educating patients about impingement syndrome, its causes, and self-management strategies presents an opportunity to empower individuals in managing their condition. This includes providing information on appropriate exercises, lifestyle modifications, and ergonomic practices to prevent exacerbation or recurrence of symptoms. Patient education programs and digital health solutions can be developed to improve patient knowledge, compliance, and engagement, thus leading to better treatment outcomes.
• Telemedicine and remote monitoring: The rise of telemedicine and remote monitoring technologies presents an opportunity to enhance access to impingement syndrome treatment, especially for patients in remote or underserved areas. Virtual consultations, remote physical therapy sessions, and wearable devices can facilitate continuous monitoring of symptoms and progress. These technological advancements can improve convenience, reduce healthcare costs, and expand the reach of impingement syndrome treatment.
• Personalized medicine and precision diagnosis: Advancements in genomics and molecular diagnostics offer opportunities for personalized medicine in global impingement syndrome treatment. By identifying specific genetic markers or biomarkers which are associated with the condition, healthcare professionals can tailor treatment plans to individual patients, thus optimizing therapeutic outcomes. Precision diagnosis techniques, such as biomarker-based imaging or genetic testing, can aid in early detection, accurate prognosis, and targeted interventions.

Global Impingement Syndrome Market Trends:

• Integration of technology: Technology is playing an increasingly significant role in global impingement syndrome treatment. Robotics and computer-assisted surgery are being utilized to enhance the precision and accuracy of surgical interventions. Advanced imaging techniques, such as 3D imaging or intraoperative ultrasound, aid in pre-operative planning and intra-operative guidance. Virtual reality (VR) and augmented reality (AR) are also being explored for patient education, surgical simulation, and rehabilitation exercises.
• Digital health solutions: Digital health solutions, including mobile applications, wearable devices, and remote monitoring tools, are being utilized to support impingement syndrome treatment and management. These technologies enable patients to track their symptoms, monitor their progress, and receive guidance on exercises and self-care. They also facilitate remote communication and virtual consultations between patients and healthcare professionals, thus improving access to care and patient engagement.
• Multi-disciplinary approach: There is a growing trend towards a multi-disciplinary approach in the management of impingement syndrome. Orthopedic surgeons, physical therapists, sports medicine specialists, and pain management experts are collaborating to provide comprehensive and individualized treatment plans. This approach emphasizes a holistic view of the patient's condition, thus addressing not only the structural issues but also considering factors such as biomechanics, muscle imbalances, and lifestyle modifications.

Global Impingement Syndrome Market Restraints:

• High cost of treatment: The cost of impingement syndrome treatment, including diagnostic tests, medications, physical therapy, and surgical interventions, can be a significant restraint for patients. Health insurance coverage may vary, and out-of-pocket expenses can be burdensome for individuals without adequate coverage. The high cost of treatment may limit access to care, particularly for those with limited financial resources, and thereby hinder the market growth.
• Limited reimbursement policies: Reimbursement policies and coverage limitations imposed by healthcare payers can pose a restraint on the global impingement syndrome market. These policies may restrict access to certain treatments or impose criteria that must be met before reimbursement is provided. Limited reimbursement options for certain procedures or therapies can impact the adoption and availability of innovative treatments, thus potentially slowing down market growth.
• Variability in treatment outcomes: The variability in treatment outcomes for impingement syndrome can be a restraint on the market growth. While many patients experience significant improvement with conservative treatments or surgical interventions, some individuals may have persistent symptoms or limited functional recovery. The unpredictability of individual responses to treatment can lead to patient dissatisfaction and reluctance to seek further treatment, thus impacting the market growth.
• Counterbalance: Reimbursement policies should not provide restrictions in carrying out the different therapies and the procedures of the impingement syndrome. Proper health insurance policy should be applicable in performing the treatment of the impingement syndrome, as the treatment cost associated is very high.

Figure 2. Global Impingement Syndrome Market Share (%), By Type, 2023

To learn more about this report, request sample copy

Recent Developments

• Advanced surgical techniques: There have been advancements in surgical techniques for the treatment of impingement syndrome, including minimally invasive arthroscopic procedures. These techniques involve smaller incisions, reduced tissue trauma, and faster recovery times as compared to traditional open surgery.
• Regenerative medicine: The use of regenerative medicine approaches, such as platelet-rich plasma (PRP) injections or stem cell therapy, has been explored for the treatment of impingement syndrome. These therapies aim to promote tissue healing and regeneration.
• Rehabilitation Protocols: There have been developments in rehabilitation protocols and physical therapy techniques for individuals with impingement syndrome. These protocols focus on strengthening the shoulder muscles, improving range of motion, and thereby optimizing biomechanics to alleviate impingement symptoms.

Acquisition, Collaboration and Partnership

• In November 2022, Arthrex, one of the leader in multispecialty, minimally invasive surgical technology, medical research, manufacturing and medical education and Richard Wolf, a full-service provider in endoscopy, offering a wide range of instrumentation and system solutions for minimally invasive medicine announced a U.S.-based partnership to offer comprehensive technology and product offerings in urology, gynecology and general surgery.
• In August 2022, CONMED Corporation acquired Biorez, Inc. CONMED Corporation, a medical technology company that provides surgical devices and equipment for minimally invasive procedures announced a definitive agreement to Acquire Biorez, Inc., a U.S. based medical device start-up focused on advancing the healing of soft tissues using its proprietary BioBrace Implant technology.
• In July 2022, Bioventus Inc., one of the global leader of innovations for active healing and surgical orthobiologics announced that it has completed its acquisition of CartiHeal., a privately-held medical device company to add CartiHeal to our diverse portfolio of active healing solutions.
• In July 2021, Celularity Inc., a clinical-stage biotechnology company developing innovative cell therapies and biomaterial products and Arthrex, Inc., one of global leader in minimally invasive orthopedic technology announced that both the companies have entered into an exclusive partnership to distribute and commercialize CelularityInc.’s biomaterial products for orthopedic surgery and sports medicine.

Top Companies in Global Impingement Syndrome Market

• Johnson & Johnson (DePuy Synthes)
• Medtronic plc
• Breg, Inc.
• CONMED Corporation
• Össur hf.
• Colfax
• Globus Medical, Inc.
• Wright Medical Group N.V.
• Arthrex, Inc.
• Orthofix Medical Inc.
• Bioventus LLC

*Definition: Impingement syndrome which is also known as shoulder impingement is a musculoskeletal condition that occurs when the tendons and bursa in the shoulder become compressed or irritated. It typically results from repetitive overhead activities or age-related degenerative changes in the shoulder joint. The compression causes pain, inflammation, and limited range of motion in the shoulder. The common symptoms include shoulder pain, weakness, and difficulty performing certain movements.